Lesya V Zelenchuk1, Anne-Marie Hedge1, Peter S N Rowe2. 1. The Kidney Institute, Kansas University Medical Center, Kansas City, KS, USA. 2. The Kidney Institute, Kansas University Medical Center, Kansas City, KS, USA. Electronic address: prowe@kumc.edu.
Abstract
CONTEXT: Mice with null mutations in matrix extracellular phosphoglycoprotein (MEPE) have increased bone mass, increased trabecular density and abnormal cancellous bone (MN-mice). These defects worsen with age and MEPE overexpression induces opposite effects. Also, genome wide association studies show that MEPE plays a major role in bone mass. We hypothesized that the conserved C-terminal MEPE ASARM-motif is chiefly responsible for regulating bone mass and trabecular structure. DESIGN: To test our theory we overexpressed C-terminal ASARM-peptide in MN-mice using the Col1α1 promoter (MNAt-mice). We then compared the bone and renal phenotypes of the MNAt-mouse with the MN-mouse and the X-linked hypophosphatemic rickets mouse (HYP). The HYP mouse overexpresses ASARM-peptides and is defective for the PHEX gene. RESULTS: The MN-mouse developed increased bone mass, bone strength and trabecular abnormalities that worsened markedly with age. Defects in bone formation were chiefly responsible with suppressed sclerostin and increased active β-catenin. Increased uric acid levels also suggested that abnormalities in purine-metabolism and a reduced fractional excretion of uric acid signaled additional renal transport changes. The MN mouse developed a worsening hyperphosphatemia and reduced FGF23 with age. An increase in the fractional excretion of phosphate (FEP) despite the hyperphosphatemia confirms an imbalance in kidney-intestinal phosphate regulation. Also, the MN mice showed an increased creatinine clearance suggesting hyperfiltration. A reversal of the MN bone-renal phenotype changes occurred with the MNAt mice including the apparent hyperfiltration. The MNAt mice also developed localized hypomineralization, hypophosphatemia and increased FGF23. CONCLUSIONS: The C-terminal ASARM-motif plays a major role in regulating bone-mass and cancellous structure as mice age. In healthy mice, the processing and release of free ASARM-peptide are chiefly responsible for preserving normal bone and renal function. Free ASARM-peptide also affects renal mineral phosphate handling by influencing FGF23 expression. These findings have implications for understanding age-dependent osteoporosis, unraveling drug-targets and developing treatments.
CONTEXT: Mice with null mutations in matrix extracellular phosphoglycoprotein (MEPE) have increased bone mass, increased trabecular density and abnormal cancellous bone (MN-mice). These defects worsen with age and MEPE overexpression induces opposite effects. Also, genome wide association studies show that MEPE plays a major role in bone mass. We hypothesized that the conserved C-terminal MEPE ASARM-motif is chiefly responsible for regulating bone mass and trabecular structure. DESIGN: To test our theory we overexpressed C-terminal ASARM-peptide in MN-mice using the Col1α1 promoter (MNAt-mice). We then compared the bone and renal phenotypes of the MNAt-mouse with the MN-mouse and the X-linked hypophosphatemic ricketsmouse (HYP). The HYPmouse overexpresses ASARM-peptides and is defective for the PHEX gene. RESULTS: The MN-mouse developed increased bone mass, bone strength and trabecular abnormalities that worsened markedly with age. Defects in bone formation were chiefly responsible with suppressed sclerostin and increased active β-catenin. Increased uric acid levels also suggested that abnormalities in purine-metabolism and a reduced fractional excretion of uric acid signaled additional renal transport changes. The MN mouse developed a worsening hyperphosphatemia and reduced FGF23 with age. An increase in the fractional excretion of phosphate (FEP) despite the hyperphosphatemia confirms an imbalance in kidney-intestinal phosphate regulation. Also, the MN mice showed an increased creatinine clearance suggesting hyperfiltration. A reversal of the MN bone-renal phenotype changes occurred with the MNAtmice including the apparent hyperfiltration. The MNAtmice also developed localized hypomineralization, hypophosphatemia and increased FGF23. CONCLUSIONS: The C-terminal ASARM-motif plays a major role in regulating bone-mass and cancellous structure as mice age. In healthy mice, the processing and release of free ASARM-peptide are chiefly responsible for preserving normal bone and renal function. Free ASARM-peptide also affects renal mineral phosphate handling by influencing FGF23 expression. These findings have implications for understanding age-dependent osteoporosis, unraveling drug-targets and developing treatments.
Authors: Gerald J Atkins; Peter S Rowe; Hui P Lim; Katie J Welldon; Renee Ormsby; Asiri R Wijenayaka; Lesya Zelenchuk; Andreas Evdokiou; David M Findlay Journal: J Bone Miner Res Date: 2011-07 Impact factor: 6.741
Authors: Marcelo Campos; Constance Couture; Izaura Y Hirata; Maria A Juliano; Thomas P Loisel; Philippe Crine; Luiz Juliano; Guy Boileau; Adriana K Carmona Journal: Biochem J Date: 2003-07-01 Impact factor: 3.857
Authors: Lori C Gowen; Donna N Petersen; Amy L Mansolf; Hong Qi; Jeffrey L Stock; George T Tkalcevic; Hollis A Simmons; David T Crawford; Kristen L Chidsey-Frink; Hua Zhu Ke; John D McNeish; Thomas A Brown Journal: J Biol Chem Date: 2002-11-05 Impact factor: 5.157
Authors: Iraj Nabipour; Philip N Sambrook; Fiona M Blyth; Margaret R Janu; Louise M Waite; Vasi Naganathan; David J Handelsman; David G Le Couteur; Robert G Cumming; Markus J Seibel Journal: J Bone Miner Res Date: 2011-05 Impact factor: 6.741
Authors: Nasreen Azam; Martin Y H Zhang; Xuemei Wang; Harriet S Tenenhouse; Anthony A Portale Journal: Endocrinology Date: 2003-08 Impact factor: 4.736
Authors: Olivia C Eller; Rena N Stair; Christopher Neal; Peter S N Rowe; Jennifer Nelson-Brantley; Erin E Young; Kyle M Baumbauer Journal: Neurobiol Pain Date: 2022-06-17
Authors: Heather A L Riddle; Shiqin Zhang; Feng Qian; James C Williams; Jason R Stubbs; Peter Stanley N Rowe; Stephen C Parnell Journal: Am J Physiol Renal Physiol Date: 2022-03-28
Authors: Peter S N Rowe; Lesya V Zelenchuk; Jennifer S Laurence; Phil Lee; William M Brooks; Ellen T McCarthy Journal: Am J Physiol Renal Physiol Date: 2015-09-02
Authors: Oswald Matika; Valentina Riggio; Marie Anselme-Moizan; Andrew S Law; Ricardo Pong-Wong; Alan L Archibald; Stephen C Bishop Journal: Genet Sel Evol Date: 2016-02-08 Impact factor: 4.297
Authors: Cristopher V Van Hout; Ioanna Tachmazidou; Joshua D Backman; Joshua D Hoffman; Daren Liu; Ashutosh K Pandey; Claudia Gonzaga-Jauregui; Shareef Khalid; Bin Ye; Nilanjana Banerjee; Alexander H Li; Colm O'Dushlaine; Anthony Marcketta; Jeffrey Staples; Claudia Schurmann; Alicia Hawes; Evan Maxwell; Leland Barnard; Alexander Lopez; John Penn; Lukas Habegger; Andrew L Blumenfeld; Xiaodong Bai; Sean O'Keeffe; Ashish Yadav; Kavita Praveen; Marcus Jones; William J Salerno; Wendy K Chung; Ida Surakka; Cristen J Willer; Kristian Hveem; Joseph B Leader; David J Carey; David H Ledbetter; Lon Cardon; George D Yancopoulos; Aris Economides; Giovanni Coppola; Alan R Shuldiner; Suganthi Balasubramanian; Michael Cantor; Matthew R Nelson; John Whittaker; Jeffrey G Reid; Jonathan Marchini; John D Overton; Robert A Scott; Gonçalo R Abecasis; Laura Yerges-Armstrong; Aris Baras Journal: Nature Date: 2020-10-21 Impact factor: 69.504